Vivaswan Agro Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.18 M
as on 24-10-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.09 Cr
as on 24-10-2024
- Revenue %
(FY 2023)
- Profit -893.09%
(FY 2023)
- Ebitda -5837.92%
(FY 2023)
- Net Worth 3653.27%
(FY 2023)
- Total Assets 8927.39%
(FY 2023)
About Vivaswan Agro Pharma
The Corporate was formerly known as Vivaswan Ias Academy Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.18 M.
The company currently has active open charges totaling ₹6.09 Cr.
Adnan Manasawala and Abhisheksingh Baghel serve as directors at the Company.
- CIN/LLPIN
U80904MP2019PTC047723
- Company No.
047723
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Feb 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vivaswan Agro Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Adnan Manasawala  | Director | 15-Mar-2023 | Current |
| Abhisheksingh Baghel | Director | 06-Feb-2019 | Current |
Financial Performance of Vivaswan Agro Pharma.
Vivaswan Agro Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 893.09% decrease in profit. The company's net worth Soared by an impressive increase of 3653.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vivaswan Agro Pharma?
In 2023, Vivaswan Agro Pharma had a promoter holding of 36.01% and a public holding of 63.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eagle Techsec Communications India Private LimitedActive 14 years 5 monthsAdnan Manasawala is a mutual person
Meta Personal Care Limited Liability Par TnershipActive 7 years 2 monthsAdnan Manasawala is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Nov 2023 | ₹0.92 M | Open |
State Bank Of India Creation Date: 12 Sep 2023 | ₹6.00 Cr | Open |
How Many Employees Work at Vivaswan Agro Pharma?
Unlock and access historical data on people associated with Vivaswan Agro Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vivaswan Agro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivaswan Agro Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
